BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17961651)

  • 1. Role of complement and complement regulators in the removal of apoptotic cells.
    Trouw LA; Blom AM; Gasque P
    Mol Immunol; 2008 Mar; 45(5):1199-207. PubMed ID: 17961651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-binding lectin engagement with late apoptotic and necrotic cells.
    Nauta AJ; Raaschou-Jensen N; Roos A; Daha MR; Madsen HO; Borrias-Essers MC; Ryder LP; Koch C; Garred P
    Eur J Immunol; 2003 Oct; 33(10):2853-63. PubMed ID: 14515269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
    Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
    Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis.
    Cole DS; Hughes TR; Gasque P; Morgan BP
    Mol Immunol; 2006 May; 43(12):1953-64. PubMed ID: 16406094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of late apoptotic/necrotic cell clearance.
    Poon IK; Hulett MD; Parish CR
    Cell Death Differ; 2010 Mar; 17(3):381-97. PubMed ID: 20019744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.
    Grevink ME; Horst G; Limburg PC; Kallenberg CG; Bijl M
    J Autoimmun; 2005 Jun; 24(4):329-36. PubMed ID: 15927794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLE--a disease of clearance deficiency?
    Munoz LE; Gaipl US; Franz S; Sheriff A; Voll RE; Kalden JR; Herrmann M
    Rheumatology (Oxford); 2005 Sep; 44(9):1101-7. PubMed ID: 15928001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and systemic lupus erythematosus.
    Sheriff A; Gaipl US; Voll RE; Kalden JR; Herrmann M
    Rheum Dis Clin North Am; 2004 Aug; 30(3):505-27, viii-ix. PubMed ID: 15261339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death.
    Gaipl US; Kuenkele S; Voll RE; Beyer TD; Kolowos W; Heyder P; Kalden JR; Herrmann M
    Cell Death Differ; 2001 Apr; 8(4):327-34. PubMed ID: 11550084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells.
    Honoré C; Hummelshoj T; Hansen BE; Madsen HO; Eggleton P; Garred P
    Arthritis Rheum; 2007 May; 56(5):1598-607. PubMed ID: 17469142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells.
    Roos A; Xu W; Castellano G; Nauta AJ; Garred P; Daha MR; van Kooten C
    Eur J Immunol; 2004 Apr; 34(4):921-9. PubMed ID: 15048702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apoptosis in systemic lupus erythematosus].
    Marai I; Zandman-Goddard G; Sheonfeld Y
    Harefuah; 2003 Dec; 142(12):844-7, 877, 876. PubMed ID: 14702753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).
    Janko C; Schorn C; Grossmayer GE; Frey B; Herrmann M; Gaipl US; Munoz LE
    Autoimmun Rev; 2008 Oct; 8(1):9-12. PubMed ID: 18703173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel roles of complement in systemic lupus erythematosus--hypothesis for a pathogenetic vicious circle.
    Sturfelt G; Bengtsson A; Klint C; Nived O; Sjöholm A; Truedsson L
    J Rheumatol; 2000 Mar; 27(3):661-3. PubMed ID: 10743804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells.
    Kang YH; Urban BC; Sim RB; Kishore U
    Immunobiology; 2012 Apr; 217(4):455-64. PubMed ID: 22088229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT; Botto M
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance deficiency--a potential link between infections and autoimmunity.
    Schulze C; Munoz LE; Franz S; Sarter K; Chaurio RA; Gaipl US; Herrmann M
    Autoimmun Rev; 2008 Oct; 8(1):5-8. PubMed ID: 18790092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.